Calyxt announces strategic hires in business development and manufacturing

Continued investment in key hires to strategically position company for future growth and scale roseville, minn. , april 26, 2022 /prnewswire/ -- calyxt, inc.  (nasdaq: clxt), a plant-based synthetic biotechnology company, yesterday welcomed the second of two director-level hires in areas critical to the continued advancement of the company's key technology and business development goals.
CLXT Ratings Summary
CLXT Quant Ranking